Literature DB >> 11520182

Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes.

B Fuss1, F S Afshari, R J Colello, W B Macklin.   

Abstract

In demyelinating diseases, such as multiple sclerosis, an upregulation of MHC class I expression is thought to contribute to oligodendrocyte/myelin damage. In order to investigate potential physiological consequences of upregulated MHC class I expression in oligodendrocytes, we generated transgenic mice that overexpress H-2L(d) under the control of the proteolipid protein (PLP) promoter (PLP-L(d) mice). We focused our studies on the MHC class I molecule H-2L(d), because of its unique intracellular transport characteristics. In the CNS of PLP-L(d) mice, H-2L(d) was expressed by oligodendrocytes. Furthermore, H-2L(d) protein was transported to and expressed on the surface of oligodendrocytes. Most importantly, this upregulation of MHC class I expression in the CNS of PLP-L(d) mice did not by itself result in a de- or dysmyelinating phenotype. These transgenic mice are likely to provide a unique and novel tool for the analysis of potential roles of MHC class I-mediated mechanisms in demyelinating pathologies. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520182     DOI: 10.1006/mcne.2001.1011

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  14 in total

1.  Blocking Autophagy in Oligodendrocytes Limits Functional Recovery after Spinal Cord Injury.

Authors:  Sujata Saraswat Ohri; Andrew N Bankston; S Ashley Mullins; Yu Liu; Kariena R Andres; Jason E Beare; Russell M Howard; Darlene A Burke; Amberly S Riegler; Allison E Smith; Michal Hetman; Scott R Whittemore
Journal:  J Neurosci       Date:  2018-05-23       Impact factor: 6.167

Review 2.  Genetic dissection of neural circuits and behavior in Mus musculus.

Authors:  Robbert Havekes; Ted Abel
Journal:  Adv Genet       Date:  2009       Impact factor: 1.944

3.  Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice.

Authors:  Patricia A Wight; Cynthia S Duchala; H Elizabeth Shick; Tatyana I Gudz; Wendy B Macklin
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

4.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.

Authors:  Marina O Ziehn; Andrea A Avedisian; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2010-02-15       Impact factor: 5.662

5.  Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.

Authors:  Hariharasubramanian Ramakrishnan; Kerstin Khalaj Hedayati; Renate Lüllmann-Rauch; Carsten Wessig; Simon Ngamli Fewou; Helena Maier; Hans-Hilmar Goebel; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

6.  Focal adhesion kinase (FAK): A regulator of CNS myelination.

Authors:  Audrey D Forrest; Hilary E Beggs; Louis F Reichardt; Jeffrey L Dupree; Raymond J Colello; Babette Fuss
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

7.  Overexpression of the 3'-untranslated region of myelin proteolipid protein mRNA leads to reduced expression of endogenous proteolipid mRNA.

Authors:  Barbara S Mallon; Wendy B Macklin
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

8.  Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.

Authors:  Wensheng Lin; Yifeng Lin; Jin Li; Ali G Fenstermaker; Sharon W Way; Benjamin Clayton; Stephanie Jamison; Heather P Harding; David Ron; Brian Popko
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

9.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

10.  PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.

Authors:  Yifeng Lin; Guangcun Huang; Stephanie Jamison; Jin Li; Heather P Harding; David Ron; Wensheng Lin
Journal:  Am J Pathol       Date:  2013-11-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.